Results 101 to 110 of about 29,315 (207)

Efficacy of Fondaparinux compared to Enoxaparin for Deep Vein Thrombosis Prophylaxis in Lower Extremity Orthopedic Surgery [PDF]

open access: yes
Background: Deep vein thrombosis (DVT) or venous thromboembolus (VTE), is a common complication with orthopedic surgery and remains a serious problem even with multiple medications available for prophylaxis.
Fletcher, Gregg A.
core   +1 more source

The role of a malignancy in the treatment of a venous thromboembolism and superficial thrombophlebitis [PDF]

open access: yes, 2017
Cancer patients have a manifold risk of suffering from both thrombotic events and anticoagulation-related bleeding complications. For this reason, knowledge of their adequate medication is crucial.
Taanila, Anette
core  

Protocolo dolor torácico [PDF]

open access: yes, 2017
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2016/2017Thoracic pain is one of the most common symptoms in emergency rooms. About 12-15% of these are caused by an acute coronary syndrome, which can be classified in ST-elevated or non ST
Gimeno Tio, Pau
core  

Budgetary impact for the National Health System of Apixaban Prophylaxis of venous thromboembolism in patients undergoing yotal knee or hip replacement [PDF]

open access: yes, 2012
Fundamentos: Debido al elevado coste sanitario del tromboembolismo venoso (TEV) es necesario realizar análisis económicos que determinen la eficiencia de sus diferentes tratamientos farmacológicos.
Betegón Nicolás, Lourdes   +5 more
core   +1 more source

Modular synthesis of anticoagulant pentasaccharides [PDF]

open access: yes, 2015
Kutatócsoportunkban antikoaguláns hatású, szulfonsav-tartalmú heparinoid pentaszacharidok szintézisét kutatjuk. Ennek keretében olyan idraparinux mimetikumok előállításával foglalkozunk, melyekben a D, F és H glükóz egységek primer helyzetű szulfátészter-
Mező, Erika
core  

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

open access: yesDrug Design, Development and Therapy, 2016
Bruno Amato,1,2,* Rita Compagna,1,2,* Aldo Rocca,2 Tommaso Bianco,2 Marco Milone,2 Luigi Sivero,2 Gabriele Vigliotti,2 Maurizio Amato,2 Michele Danzi,2 Giovanni Aprea,2 Luca Gallelli,3,* Stefano de Franciscis,1,4,* Raffaele Serra1,4,* 1Interuniversity ...
Amato B   +12 more
doaj  

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

open access: yesTherapeutics and Clinical Risk Management, 2018
Kazuhiro Shimizu, Takuo Iiduka, Shuji Sato, Hajime Kiyokawa, Takahiro Nakagami, Hiroshi Mikamo, Masayo Kawazoe, Mao Takahashi, Mahito Noro Department of Internal Medicine, Toho University Sakura Medical Center, Sakura City, Chiba, Japan Background: For
Shimizu K   +8 more
doaj  

Home - About - Disclaimer - Privacy